AtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.25), $0.03 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $108.9 million versus the consensus estimate of $106.91 million.

GUIDANCE:

AtriCure sees FY2024 EPS of ($0.74)-($0.82), versus the consensus of ($0.76). AtriCure sees FY2024 revenue of $459-466 million, versus the consensus of $461.2 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.